about
Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma with the variant RNF213-, ATIC- and TPM3-ALK fusions is characterized by copy number gain of the rearranged ALK gene.Generation of the Fip1l1-Pdgfra fusion gene using CRISPR/Cas genome editing.Mutant JAK3 signaling is increased by loss of wild type JAK3 or by acquiring secondary JAK3 mutations in T-ALL.HOXA9 cooperates with activated JAK/STAT signaling to drive leukemia development.Cooperative Enhancer Activation by TLX1 and STAT5 Drives Development of NUP214-ABL1/TLX1-Positive T Cell Acute Lymphoblastic LeukemiaEML1-ABL1 Is Activated by Coiled-Coil-Mediated Oligomerization and Induces T-Cell Acute Lymphoblastic Leukemia or Myeloproliferative Disease in a Mouse Bone Marrow Transplant ModelSuz12 inactivation cooperates with JAK3 mutant signaling in the development of T-cell acute lymphoblastic leukemia
P50
Q38703931-7CDE3E3B-9555-4819-9331-C82AF3985C24Q42148688-1CC7E7B8-D09C-44AF-9977-7F9CC13B7F28Q47395580-6EE73A9F-C89A-4A62-B7D8-8BFFE7BF35E2Q51418506-6E2181F7-34B6-4D0B-A218-A94A948084EAQ58785945-8C3C4B70-3F92-488B-9A65-FA6F6F5D1E3EQ91274018-9058F154-DD76-49C1-9BA4-AD6F967BD9BFQ93160669-E40B68DB-E823-4E8E-9665-2A38877D0398
P50
description
researcher ORCID ID = 0000-0003-0111-0263
@en
name
Marlies Vanden Bempt
@ast
Marlies Vanden Bempt
@en
Marlies Vanden Bempt
@es
Marlies Vanden Bempt
@nl
type
label
Marlies Vanden Bempt
@ast
Marlies Vanden Bempt
@en
Marlies Vanden Bempt
@es
Marlies Vanden Bempt
@nl
prefLabel
Marlies Vanden Bempt
@ast
Marlies Vanden Bempt
@en
Marlies Vanden Bempt
@es
Marlies Vanden Bempt
@nl
P31
P496
0000-0003-0111-0263